Literature DB >> 6338932

Muscarinic receptors in pancreatic islets of the rat. Demonstration and dependence on long-term glucose environment.

V Grill, C G Ostenson.   

Abstract

The presence of muscarinic receptors in islets of Langerhans was assessed by measurement of specific binding of [3H]methylscopolamine. Specific binding was defined as total binding minus binding obtained in the presence of 1000-fold or higher excess of unlabeled methylscopolamine. At 37 degrees C specific binding was significant after 1 min and plateaued after 10 min of incubation. Displacement of label by increasing concentrations of unlabeled methylscopolamine indicated a dissociation constant of 1.5 x 10(-12) M. Effects of methylscopolamine on insulin release were evaluated from the inhibitions of cholinergic-induced insulin release. 4 x 10(-10) M methylscopolamine inhibited acetylcholine (20 microM)-induced insulin release more than 60%. Binding was not influenced by the following variations during binding incubations: changing the glucose concentration from 0 to 8.3 mM, adding rotenon (1 microM) or omitting calcium from the incubation medium. Islets kept in tissue culture exhibited higher binding when cultured at 11.1 than at 3.3 mM glucose for 96 h. It is concluded that islets contain muscarinic receptors, the binding to which can be subject to alteration by the long-term glucose environment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338932     DOI: 10.1016/0304-4165(83)90087-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas.

Authors:  E A Van der Zee; B Buwalda; J H Strubbe; A D Strosberg; P G Luiten
Journal:  Cell Tissue Res       Date:  1992-07       Impact factor: 5.249

2.  Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro.

Authors:  T R Renuka; Remya Robinson; C S Paulose
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

3.  Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man.

Authors:  V Coiro; P Chiodera; R Volpi; L d'Amato; L Camellini; G Rossi; D Pignatti; U Butturini
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

4.  Effect of a new cholinergic agonist, aclatonium napadisilate, on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; T Nakamura; Y Okabayashi; M Fujii; S Tani; T Fujisawa; S Baba
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

5.  Cholinergic stimulation of insulin release from cloned B-cell lines HIT-T15 and RINm5F.

Authors:  D G Lambert; T W Atkins
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

6.  Muscarinic-agonist and guanine nucleotide activation of polyphosphoinositide phosphodiesterase in isolated islet-cell membranes.

Authors:  M E Dunlop; R G Larkins
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

7.  Control of insulin secretion by cholinergic signaling in the human pancreatic islet.

Authors:  Judith Molina; Rayner Rodriguez-Diaz; Alberto Fachado; M Caroline Jacques-Silva; Per-Olof Berggren; Alejandro Caicedo
Journal:  Diabetes       Date:  2014-03-21       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.